GWM
THC icon

Geneos Wealth Management’s Tenet Healthcare THC Stock Holding History

Geneos Wealth Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-264
Closed -$46.5K – 3127
2025
Q2 		$46.5K Buy
264
+89
+51% +$13.4K ﹤0.01% 1609
2025
Q1 		$23.5K Buy
175
+104
+146% +$13.7K ﹤0.01% 1875
2024
Q4 		$8.96K Sell
71
-14
-16% -$2.08K ﹤0.01% 2094
2024
Q3 		$14.1K Buy
+85
New +$12.9K ﹤0.01% 1697
2023
Q3 		– Sell
-100
Closed -$8.14K – 2141
2023
Q2 		$8.14K Hold
100
– – ﹤0.01% 1628
2023
Q1 		$5.94K Hold
100
– – ﹤0.01% 1690
2022
Q4 		$4.88K Hold
100
– – ﹤0.01% 1711
2022
Q3 		$5K Hold
100
– – ﹤0.01% 1702
2022
Q2 		$5K Sell
100
-4
-4% -$278 ﹤0.01% 2208
2022
Q1 		$8K Buy
104
+4
+4% +$329 ﹤0.01% 2187
2021
Q4 		$8K Sell
100
-618
-86% -$45.2K ﹤0.01% 2276
2021
Q3 		$49K Hold
718
– – ﹤0.01% 1509
2021
Q2 		$49K Buy
718
+100
+16% +$6.2K ﹤0.01% 1492
2021
Q1 		$36K Hold
618
– – ﹤0.01% 1801
2020
Q4 		$32K Buy
+618
New +$19.9K ﹤0.01% 1678
2018
Q3 		– Sell
-250
Closed -$8K – 2449
2018
Q2 		$8K Buy
+250
New +$7.77K ﹤0.01% 1802
2017
Q4 		– Sell
-38,653
Closed -$635K – 2214
2017
Q3 		$635K Buy
38,653
+37,653
+3,765% +$638K 0.06% 261
2017
Q2 		$19K Sell
1,000
-791
-44% -$13.8K ﹤0.01% 1298
2017
Q1 		$31K Sell
1,791
-19,495
-92% -$362K ﹤0.01% 1078
2016
Q4 		$315K Buy
21,286
+21,189
+21,844% +$380K 0.04% 353
2016
Q3 		$2K Buy
97
+51
+111% +$1.33K ﹤0.01% 1814
2016
Q2 		$1K Hold
46
– – ﹤0.01% 1771
2016
Q1 		$1K Buy
+46
New +$1.2K ﹤0.01% 1752

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geneos Wealth Management's THC Position: Q3 2025 in Review

Geneos Wealth Management sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 264 shares — an estimated $46.5K sold.

Geneos Wealth Management first reported a position in THC in Q1 2016 and held it in 23 quarters. The position peaked at $635K in Q3 2017. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Geneos Wealth Management reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 264 Tenet Healthcare shares in Q3 2025, an estimated $46.5K.
  • Geneos Wealth Management first reported a position in Tenet Healthcare in Q1 2016 and held it in 23 quarters.
  • Geneos Wealth Management's Tenet Healthcare position peaked at $635K in Q3 2017.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.